924
Views
17
CrossRef citations to date
0
Altmetric
Review Article

Normal flora and bacterial vaginosis in pregnancy: an overview

, , &
Pages 352-363 | Received 23 Apr 2014, Accepted 11 Aug 2014, Published online: 02 Apr 2015

References

  • Aagaard K, Riehle K, Ma J, et al. (2012). A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One 7: e36466 (1--15)
  • Akinbiyi AA, Watson R, Feyi-Waboso P. (2008). Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of a prospective study. Arch Gynecol Obstet 278:463–6
  • Amsel R, Totten PA, Speigel CA, et al. (1983). Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14–22
  • Antonio MA, Hawes SE, Hillier SL. (1999). The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infec Dis 180:1950–6
  • Armstrong NR, Wilson JD. (2010). Tinidazole in the treatment of bacterial vaginosis. Int J Womens Health 1:59–65
  • Berger BJ, Kolton J, Zenilman JM, et al. (1995). Bacterial vaginosis in Lesbians: a sexually transmitted disease. Clin Inf Dis 21:1402–5
  • Boskey ER, Atherly-Trim SA, O'Campo PJ, et al. (2004). Acceptability of a self-sampling technique to collect vaginal smears for gram stain diagnosis of bacterial vaginosis. Women's Health Issues? 14:14–8
  • Bradshaw CS, Tabrizi SN, Fairley CK, et al. (2006). The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 194:828–36
  • Bradshaw CS, Vodstrcil LA, Hocking JS, et al. (2013). Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis 56:777–86
  • Briese V, Neumann G, Waldschläger J, et al. (2011). Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch Gynecol Obstet 283:585–90
  • Brocklehurst P, Gordon A, Heatley E, Milan SJ. (2013). Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev Issue 1. Art. No.: CD000262. doi: 10.1002/14651858.CD000262.pub4
  • Brotman RM, Ravel J. (2008). Ready or not: the molecular diagnosis of bacterial vaginosis. Clin Infect Dis 47:44–6
  • Bunge KE, Beigi RH, Meyn LA, Hillier SL. (2009). The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis 36:711–3
  • Castro J, Henriques A, Machado A, et al. (2013). Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells. Intern J Med Sci 10:1193–8
  • Cauci S. (2004). Vaginal immunity in bacterial vaginosis. Curr Infect Dis Rep 6:450–6
  • Cauci S, Culhane JF. (2011). High sialidase levels increase preterm birth risk among women who are bacterial vaginosis-positive in early gestation. Am J Obstet Gynecol 204:142.e1–9
  • Centers for Disease Control and Prevention. (2010). Sexually transmitted diseases treatment guidelines: bacterial vaginosis. Available from: http://www.cdc.gov/std/bv/treatment [last accessed 22 Aug 2012]
  • Centers for Disease Control and Prevention. (2013). Fact sheet: bacterial vaginosis. Available from: http://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm [last accessed 13 Mar 2013]
  • Cherpes TL, Hillier SL, Meyn LA, et al. (2008). A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 35:78–83
  • Cohen CR, Duerr A, Pruithithada N, et al. (1995). Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9:1093–7
  • Coleman JS, Hitti J, Bukusi EA, et al. (2007). Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 21:755–9
  • Cruciani F, Wasinger V, Turroni S, et al. (2013). Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment. J Antimicrob Chemother 68:2648–59
  • Danielsson D, Teigen PK, Moi H. (2011). The genital econiche: focus on microbiota and bacterial vaginosis. Ann N Y Acad Sci 1230:48–58
  • De Backer E, Verhelst R, Verstraelen H, et al. (2006). Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis 6:51.e1–6
  • Denney JM, Culhane JF. (2009). Bacterial vaginosis: a problematic infection from both a perinatal and neonatal perspective. Semin Fetal Neonatal Med 14:200–3
  • Diaz N, Dessì D, Dessole S, et al. (2010). Rapid detection of co-infections by Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex polymerase chain reaction. Diagn Microbiol Infect Dis 67:30–6
  • Donati L, Di Vico A, Spagnuolo T, et al. (2010). Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet 281:589–600
  • Donders GGG. (2007). Definition and classification of abnormal vaginal flora. Best Prac Res Clin Obstet Gynecol 21:355–73
  • Donders GGG, Guaschino S, Peters K, et al. (2013). A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis. Int J Gynaecol Obstet 120:131–6
  • Donders GGG, Van Bulck B, Caudron J, et al. (2000). Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 183:431–7
  • Eschenbach DA. (1993). Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis 16:S282–7
  • Eschenbach DA. (1997). Amniotic fluid infection and cerebral palsy. Focus on the fetus. JAMA 278:247–8
  • Ferris DG, Litaker MS, Woodward L, et al. (1995). Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 41:443–9
  • Ferris MJ, Masztal A, Aldridge KE, et al. (2004). Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4:5.e1–8
  • Fethers KA, Fairley CK, Hocking JS, et al. (2008). Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 47:1426–35
  • Fredricks DN, Fiedler TL, Marrazzo JM. (2005). Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353:1899–911
  • Fredricks DN, Fiedler TL, Thomas KK, et al. (2007). Targeted polymerase-chain-reaction for the detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 45:3270–6
  • Fredricks DN, Fiedler TL, Thomas KK, et al. (2009). Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol 47:721–6
  • García-Castillo M, Morosini MI, Gálvez M, et al. (2008). Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates. J Antimicrob Chemother 62:1027–30
  • Gardner HL, Dukes CD. (1955). Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol 69:962–76
  • Genc MR, Karas AE, Onderdonk AB, et al. (2005). Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women. AmJ Obstet Gynecol 192:916–21
  • Genc MR, Delaney ML, Onderdonk AB, Witkin SS. (2006). Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol 56:86–90
  • Genc MR, Onderdonk A. (2011). Endogenous bacterial flora in pregnant women and the influence of maternal genetic variation. BJOG 118:154–63
  • Giraldo P, Neuer A, Korneeva IL, et al. (1999). Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis. Am J Obstet Gynecol 180:524–9
  • Goffinet F, Maillard F, Mihoubi N, et al. (2003). Bacterial vaginosis: prevalence and predictive value for premature delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol 108:146–51
  • Govender L, Hoosen AA, Moodley J, et al. (1996). Bacterial vaginosis and associated infections in pregnancy. Int J Gynaecol Obstet 55:23–8
  • Greene JF III, Kuehl TJ, Allen SR. (2000). The Papanicolaou smear: inadequate screening test for bacterial vaginosis during pregnancy. Am J Obstet Gynecol 182:1048–9
  • Grether JK, Nelson KB. (2000). Possible decrease in prevalence of cerebral palsy in premature infants? J Pediatr 136:133
  • Greub G. (2012). Culturomics : a new approach to study the human microbiome, Clin Microbiol Infect 18:7–9
  • Guédou FA, Van Damme L, Deese J, Crucitti T, Mirembe F, Solomon S, Bekker M, Alary M. (2014). Intermediate vaginal flora and bacterial vaginosis are associated with the same factors: findings from an exploratory analysis among female sex workers in Africa and India. Sex Transm Infect, 90:61–4
  • Guaschino S, De Seta F, Piccoli M, et al. (2006). Aetiology of preterm labour: bacterial vaginosis. BJOG 113:46–51
  • Guerra B, Ghi T, Quarta S, et al. (2006). Pregnancy outcome after early detection of bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 128:40–5
  • Guise JM, Mahon SM, Aickin M, et al. (2001). Screening for bacterial vaginosis in pregnancy. Am J Prev Med 20:62–72
  • Harper LM, Parry S, Stamilio DM, et al. (2012). The interaction effect of bacterial vaginosis and periodontal disease on the risk of preterm delivery. Am J Perinatol 29:347–52
  • Hauth JC, MacPherson C, Carey JC, et al. (2003). Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 188:831–5
  • Hay PE. (2000). Recurrent bacterial vaginosis. Curr Infect Dis Rep 2:506–12
  • Hay PE. (2010). Bacterial vaginosis. Medicine 38:281–5
  • Hay PE, Morgan DJ, Ison CA, et al. (1994). A longitudinal study of bacterial vaginosis during pregnancy. BJOG 101:1048–53
  • Hickey DK, Patel MV, Fahey JV, Wira CR. (2011). Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88:185–94
  • Hillier SL, Nugent RP, Eschenbach DA, et al. (1995). Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333:1737–42
  • Hogan VK, Culhane JF, Hitti J, et al. (2007). Relative performance of three methods for diagnosing bacterial vaginosis during pregnancy. Matern Child Health J 11:532–9
  • Holst E. (1990). Reservoir of four organisms associated with bacterial vaginosis suggests lack of sexual transmission. J Clin Microbiol 28:2035–9
  • Hooven TA, Randis TM, Hymes SR, et al. (2012). Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity. Am J Obstet Gynecol 101:2870–2
  • Howe L, Wiggins R, Soothill PW, et al. (1999). Mucinases and sialidase activity of the vaginal microflora: implica- tions for the pathogenesis of preterm labour. Int J STD AIDS, 10:442–7
  • Huggins GR, Preti G. (1976). Volatile constituents of human vaginal secretions. Am J Obstet Gynecol 126:129–36
  • Hyman RW, Fukushima M, Jiang H, et al. (2014). Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci 21:32–40
  • Ison CA, Hay PE. (2002). Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 78:413–5
  • Johnson LF, Dorrington RE, Bradshaw D, Coetzee DJ. (2011). The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Healthcare 2:13–20
  • Johnson LF, Lewis DA. (2008). The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 35:946–59
  • Kinghorn GR, Jones BM, Chowdhury FH, Geary I. (1982). Balanoposthitis associated with Gardnerella vaginalis infection in men. Br J Vener Dis 58:127–9
  • Kiss H, Kögler B, Petricevic L, et al. (2007). Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. BJOG 114:1402–7
  • Klatt TE, Cole DC, Eastwood DC, Barnabei VM. (2010). Factors associated with recurrent bacterial vaginosis. J Reprod Med 55:55–61
  • Klebanoff MA, Hauth JC, MacPherson CA, et al. (2004). Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 190:363–70
  • Koumans EH, Sternberg M, Bruce C, et al. (2007). The prevalence of bacterial vaginosis in the United States, 2001-2004; Associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 11:864–9
  • Krauss-Silva L, Almada-Horta A, Alves MB, et al. (2014). Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population. BMC Pregn Childbirth 14:1–10
  • Kurki T, Sivonen A, Renkonen O-V, et al. (1992). Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 80:173–7
  • Laghi L, Picone G, Cruciani F, et al. (2014). Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob Agents Chemother 58:3411–20
  • Lagier J-C, Armougom F, Million M, Hugon P, Pagnier I, Robert C, Bittar F, Fournous G, Gimenez G, Maraninchi M, Trape J-F, Koonin EV, La Scola B, Raoult D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect, 18:1185–93
  • Lambert JA, John S, Sobel JD, Akins RA. (2013a). Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process. PLoS ONE 8:e82599 (1--10)
  • Lambert JA, Kalra A, Dodge CT, et al. (2013b). Novel PCR-based methods enhance characterization of vaginal microbiota in a bacterial vaginosis patient before and after treatment. Appl Environ Microbiol 79:4181–5
  • Leitich H. (2003). Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 188:752–8
  • Leitich H, Kiss H. (2007). Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynecol 21:375–90
  • Lewis DA, Maruma E. (2010). Revision of the national guideline for first-line comprehensive management and control of sexually transmitted infections: what's new and why? South Afr J Epidemiol Infect 24:6–9
  • Lin L, Yang H, Su J. (2011). Vaginal Lactobacillus distributions and functions in pregnant women. J Microbiol 5:1224–30
  • Ling ZD, Chang Q, Lipton JW, et al. (2004). Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124:619–28
  • Livengood CH. (2009). Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol 2:28–37
  • Lockitch G. (2004). Maternal-foetal risk assessment. Clin Biochem 37:447–9
  • Löfmark S, Edlund C, Nord CE. (2010). Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 50:S16–23
  • Macklaim JM, Fernandes AD, Di Bella JM, et al. (2013). Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 1:1–11. doi:10.1186/2049-2618-1-12
  • Marconi C, Cruciani F, Vitali B, Donders GGG. (2012). Correlation of Atopobium vaginae amount with bacterial vaginosis markers. Pathology 16:127–32
  • Marconi C, Donders GG, Parada CMGL, et al. (2013). Do Atopobium vaginae, Megasphaera sp. and Leptotrichia sp. change the local innate immune response and sialidase activity in bacterial vaginosis? Sex Transm Infect 89:167–73
  • McDonald HM, O'Loughlin JA, Vigneswaran R, et al. (1994). Bacterial vaginosis in pregnancy and efficacy of short course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 84:343–8
  • McDonald HM, Brocklehurst P, Gordon A. (2007). Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev, Issue 1. Art. No.: CD000262. doi:10.1002/14651858.CD000262.pub3
  • McGregor JA, French JI, Jones W, et al. (1994). Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 170:1048–60
  • McGregor JA, French JL, Parker R, et al. (1995). Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 173:157–67
  • Menard J, Fenollar F, Raoult D, Boubli L. (2012). Self-collected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis 31:513–8
  • Menard JP, Mazouni C, Fenollar F, et al. (2010). Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram-stain identification of bacterial vaginosis. Eur J Clin Microbiol Infect Dis 29:1547–52
  • Mirmonsef P, Gilbert D, Zariffard MR, et al. (2011). The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol 65:190–5
  • Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. (2009). Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria. BMC Infect Dis 9:1–6
  • Morris MC, Rogers PA, Kinghorn GR. (2001). Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect 77:63–8
  • Myer L, Denny L, Telerant R, et al. (2005). Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 192:1372–80
  • Nelson DB, Bellamy S, Nachamkin I, et al. (2007). First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women. Fertil Steril 88:1396–403
  • Nelson DB, Macones G. (2002). Bacterial vaginosis in pregnancy: current findings and future directions. Epidemiol Rev 24:102–8
  • Nugent RP, Krohn MA, Hillier SL. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301
  • Omole-Ohonsi A, Nwokedi EE. (2011). Sociodemographic characteristics and aetiological factors of vaginal discharge in pregnancy. Jos J Med 5:27–30
  • Onderdonk AB, Lee ML, Lieberman E, et al. (2003). Quantitative microbiologic models for preterm delivery. J Clin Microbiol 41:1073–9
  • Patterson JL, Girerd PH, Karjane NW, Jefferson KK. (2007). Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol 197:170–7
  • Pereira L, Culhane J, McCollum K, et al. (2005). Variation in microbiologic profiles among pregnant women with bacterial vaginosis. Am J Obstet Gynecol 193:746–51
  • Povlsen K, Thorsen P, Lind I. (2001). Relationship of Ureaplasma urealyticum biovars to the presence or absence of bacterial vaginosis in pregnant women and to the time of delivery. Eur J Clin Microbiol Infect Dis 20:65–67
  • Pretorius C, Jagatt A, Lamont RF. (2007). The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 35:93–9
  • Pridmore RD, Berger B, Desiere F, et al. (2004). The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc Natl Acad Sci USA 101:2512–7
  • Rajan SS, Cavera VL, Zhang X, et al. (2014). Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis. Antimicrob Agents Chemother 58:2747–53
  • Ravel J, Gajer P, Abdob Z, et al. (2011). Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 108:4680–7
  • Rivkin A, Gim S. (2011). Rifaximin: new therapeutic indication and future directions. Clin Ther 33:812–27
  • Romero R, Hassan SS, Gajer P, et al. (2014). The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2:1–19. doi:10.1186/2049-2618-2-4
  • Romoren M, Velauthapillai M, Rahman M, et al. (2007) Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach. Bull World Health Organ 85:297–304
  • Royce RA, Thorp J, Granados JL, Savitz DA. (1999). Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. J Acquir Immun Defic Syndr Hum Retrovirol 20:382–6
  • Ryckman KK, Simhan HN, Krohn M, Williams SM. (2009). Cervical cytokine network patterns during pregnancy: the role of bacterial vaginosis and geographic ancestry. J Reprod Immunol 79:174–82
  • Schmid G, Markowitz L, Joesoef R, Koumans E. (2000). Bacterial vaginosis and HIV infection. Sex Transm Infect 76:3–4
  • Schoeman J. (2002). Bacterial vaginosis – a literature review. Obstet Gynecol Forum 12:8–13
  • Schwebke JR. (2009). Bacterial vaginosis: are we coming full circle? J Infect Dis 200:1633–5
  • Schwebke A, Taras D, Rusch K, Rusch V. (2006). Throwing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob 5:4–10
  • Sha BE, Chen HY, Wang QJ, et al. (2005). Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol 43:4607–12
  • Shipitsyna E, Roos A, Datcu R, et al. (2013). Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One 8:e60670 (1--10)
  • Simhan HN, Bodnar LM, Krohn MA. (2008). Paternal race and bacterial vaginosis during the first trimester of pregnancy. Am J Obstet Gynecol 198:196.e1–4
  • Sobel JD, Ferris D, Schwebke J, et al. (2006). Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 194:1283–9
  • Sobel JD, Karpas Z, Lorber A. (2012). Diagnosing vaginal infections through measurement of biogenic amines by ion mobility spectrometry. Eur J Clin Microbiol Infect Dis 163:81–4
  • Sodhani P, Garg S, Bhalla P, et al. (2005). Prevalence of bacterial vaginosis in a community setting and role of the pap smear in its detection. Acta Cytol 49:634–8
  • Spiegel CA, Amsel R, Holmes KK. (1983). Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol 18:170–7
  • Srinivasan S, Fredricks DN. (2008). The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008:1--22
  • Srinivasan U, Misra D, Marazita ML, Foxman B. (2009). Vaginal and oral microbes, host genotype and preterm birth. Med Hypotheses 73:963–75
  • Struthers BJ. (1997). Metronidazole appears not to be a human teratogen: review of the literature. Infect Dis Obstet Gynecol 5:326–35
  • Swidsinski A, Doerfell Y, Loening-Baucke V, et al. (2010). Gardnerella biofilm involves both females and males and is sexually transmitted. Gynecol Obstet Invest 70:256–63
  • Swidsinski A, Mendling W, Loening-Baucke V, et al. (2005). Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106:1013–23
  • Taha TE, Hoover DR, Dallabetta GA, et al. (1998). Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699–706
  • Tolosa JE, Chaithongwongwatthana S, Daly S, et al. (2006). The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynaecol 195:1198–204
  • Trama JP, Pascal KE, Zimmerman J, et al. (2008). Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis. Mol Cell Probes 22:96–102
  • Turovskiy Y, Noll KS, Chikindas ML. (2011). The aetiology of bacterial vaginosis. J Appl Microbiol 110:1105–28
  • Twin J, Bradshaw CS, Garland SM, et al. (2013). The potential of metatranscriptomics for identifying screening targets for bacterial vaginosis. PLoS One 8:e76892 (1--8)
  • Udayalaxmi J, Bhat G, Kotigadde S, Kotian S. (2012). Effect of pH on the adherence, surface hydrophobicity and the biofilm formation of Gardnerella vaginalis. J Clin Diagn Res 6:967–9
  • Verhelst R, Verstraelen H, Claeys G, et al. (2005). Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol 5:123–33
  • Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M. (2010). The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 10:81.e1–11
  • Walther-António MRS, Jeraldo P, Berg Miller ME, et al. (2014). Pregnancy's stronghold on the vaginal microbiome. PLoS One 9:e98514 (1--10)
  • Wang B, Xiao BB, Shang CG, et al. (2014). Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure. Eur J Clin Microbiol Infect Dis. doi 10.1007/s10096-014-2128-5
  • Waters TP, Denney JM, Mathew L, et al. (2008). Longitudinal trajectory of bacterial vaginosis during pregnancy. Am J Obstet Gynecol 199:431.e1–5
  • Wilks M, Wiggins R, Whiley A, et al. (2004). Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of pre-term birth and relation with outcome. J Clin Microbiol 42:713–7
  • Witkin SS, Linhares IM, Giraldo P. (2007a). Bacterial flora of the female genital tract: function and immune regulation. Best Prac Res Clin Obstet Gynecol 21:347–54
  • Witkin SS, Linhares IM, Giraldo P, Ledger WJ. (2007b). An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infect Dis 44:554–7
  • World Health Organization. (2005). Sexually transmitted and other reproductive tract infections: a guide to essential practice. Geneva, Switzerland. Available from: http://whqlibdoc.who.int/publications/2005/9241592656.pdf [last accessed 15 Apr 2013]
  • World Health Organization. (2014). Sexually transmitted and other reproductive tract infections: a guide to essential practice. Geneva, Switzerland. Available from: http://apps.who.int/medicinedocs/en/d/Jh2942e/4.10.html#Jh2942e.4.10 [last accessed 30 Jul 2014]
  • Yen S, Shafer M-A, Moncada J, et al. (2003). Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 102:927–33
  • Zariffard MR, Novak RM, Lurain N, et al. (2005). Induction of tumour necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 191:1913–21
  • Zhou X, Bent SJ, Schneider MG, et al. (2004). Characterisation of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150:2565–73
  • Zodzika J, Rezeberga D, Jermakova I, et al. (2011). Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand 90:41–6
  • Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. (2010). Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol 48:1812–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.